2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid

C33H29BrN2O3 — CID 123742898

IUPAC2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid
SMILESCc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C3OC3NCc3ccc(Br)cc3)cc12
InChIInChI=1S/C33H29BrN2O3/c1-20-21(2)36(19-23-7-11-24(12-8-23)27-5-3-4-6-28(27)33(37)38)30-16-13-25(17-29(20)30)31-32(39-31)35-18-22-9-14-26(34)15-10-22/h3-17,31-32,35H,18-19H2,1-2H3,(H,37,38)
InChIKeyXWNYNQQLUDUWCG-UHFFFAOYSA-N
MW581.51 g/mol
LogP7.62
Rot. Bonds8

About 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid

2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid (PubChem CID 123742898) has the molecular formula C33H29BrN2O3 and a molecular weight of 581.51 g/mol. Its IUPAC name is 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid.

Molecular Properties

Compound Name2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid
PubChem CID123742898
Molecular FormulaC33H29BrN2O3
Molecular Weight581.51 g/mol
Exact Mass580.14
IUPAC Name2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid
SMILESCc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C3OC3NCc3ccc(Br)cc3)cc12
InChIInChI=1S/C33H29BrN2O3/c1-20-21(2)36(19-23-7-11-24(12-8-23)27-5-3-4-6-28(27)33(37)38)30-16-13-25(17-29(20)30)31-32(39-31)35-18-22-9-14-26(34)15-10-22/h3-17,31-32,35H,18-19H2,1-2H3,(H,37,38)
InChIKeyXWNYNQQLUDUWCG-UHFFFAOYSA-N
XLogP7.62
TPSA66.79 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500581.51
LogP ≤ 57.62
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid?
The IUPAC name of 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid (CID 123742898) is 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid.
What is the SMILES notation for 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid?
The canonical SMILES for 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid is Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C3OC3NCc3ccc(Br)cc3)cc12.
What is the InChIKey of 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid?
The InChIKey is XWNYNQQLUDUWCG-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H29BrN2O3/c1-20-21(2)36(19-23-7-11-24(12-8-23)27-5-3-4-6-28(27)33(37)38)30-16-13-25(17-29(20)30)31-32(39-31)35-18-22-9-14-26(34)15-10-22/h3-17,31-32,35H,18-19H2,1-2H3,(H,37,38).
What are the key properties of 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid?
2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid has a molecular weight of 581.51 g/mol, XLogP of 7.62, 8 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[[5-[3-[(4-bromophenyl)methylamino]oxiran-2-yl]-2,3-dimethylindol-1-yl]methyl]phenyl]benzoic acid is sourced from PubChem (CID 123742898), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).